Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.501
-0.034 (-6.32%)
At close: Oct 29, 2024, 4:00 PM
0.499
-0.002 (-0.36%)
After-hours: Oct 29, 2024, 6:01 PM EDT

Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $11.59 million. The enterprise value is -$48.60 million.

Market Cap 11.59M
Enterprise Value -48.60M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

TSBX has 23.13 million shares outstanding. The number of shares has increased by 692.42% in one year.

Shares Outstanding 23.13M
Shares Change (YoY) +692.42%
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 3.83%
Owned by Institutions (%) 34.69%
Float 14.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.19
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.04.

Current Ratio 4.38
Quick Ratio 3.99
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -134.46% and return on invested capital (ROIC) is -85.29%.

Return on Equity (ROE) -134.46%
Return on Assets (ROA) -66.10%
Return on Capital (ROIC) -85.29%
Revenue Per Employee n/a
Profits Per Employee -$933,775
Employee Count 80
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -180,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.81% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -74.81%
50-Day Moving Average 0.59
200-Day Moving Average 2.21
Relative Strength Index (RSI) 40.29
Average Volume (20 Days) 138,725

Short Selling Information

The latest short interest is 387,819, so 1.68% of the outstanding shares have been sold short.

Short Interest 387,819
Short Previous Month 497,466
Short % of Shares Out 1.68%
Short % of Float 2.75%
Short Ratio (days to cover) 2.82

Income Statement

Revenue n/a
Gross Profit -60.67M
Operating Income -80.19M
Pretax Income -75.09M
Net Income -74.70M
EBITDA -77.83M
EBIT -80.19M
Earnings Per Share (EPS) -$3.45
Full Income Statement

Balance Sheet

The company has $62.40 million in cash and $2.20 million in debt, giving a net cash position of $60.19 million or $2.60 per share.

Cash & Cash Equivalents 62.40M
Total Debt 2.20M
Net Cash 60.19M
Net Cash Per Share $2.60
Equity (Book Value) 59.74M
Book Value Per Share 2.58
Working Capital 52.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.68 million and capital expenditures -$508,000, giving a free cash flow of -$68.18 million.

Operating Cash Flow -67.68M
Capital Expenditures -508,000
Free Cash Flow -68.18M
FCF Per Share -$2.95
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -692.42%
Shareholder Yield -692.42%
Earnings Yield -644.43%
FCF Yield -588.20%

Analyst Forecast

The average price target for TSBX is $4.75, which is 847.73% higher than the current price. The consensus rating is "Buy".

Price Target $4.75
Price Target Difference 847.73%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TSBX has an Altman Z-Score of -3.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.31
Piotroski F-Score 2